Pitching their product ideas in the predominantly male venture capital arena is a big challenge for entrepreneurs in femtech – a fast-growing field of technology for women’s health and wellness.
“Once you say ‘breast,’ ‘vagina,’ ‘menopause’ or — God forbid – ‘sexual health,’ investors turn off,” says Sharon Rashi-Elkeles, CEO and cofounder of Israeli femtech hub Eve.
Launched in May 2018 as the world’s first of its kind, Eve has spent the last 20 months making femtech startups more understandable and attractive to investors as potential game-changers.
These are products that would give women – half the world’s population – unique “tools to manage their health more innovatively, more accurately, more efficiently and with the characteristics that women like, such as design, color and comfort,” says Rashi-Elkeles.
For example, one of the Israeli startups (Lamoon) has engineered an internal probe that determines a woman’s most fertile days more accurately than temperature-taking. Two startups (GynTools and Eve Pharma) have novel solutions for diagnosing and treating vaginosis, a common gynecological infection.
Gynica proposes a cannabinoid-based treatment for endometriosis. Biop Medical is developing a new treatment for cervical cancer. Annabella is an app-connected breast pump that mimics an infant’s sucking.
NinePlusLife is beginning a pilot with an Israeli insurance company for its app that lets pregnant women chat any time with an individually matched doula.-- More...
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.
Pitching their product ideas in the predominantly male venture capital arena is a big challenge for entrepreneurs in femtech – a fast-growing field of technology for women’s health and wellness.
“Once you say ‘breast,’ ‘vagina,’ ‘menopause’ or — God forbid – ‘sexual health,’ investors turn off,” says Sharon Rashi-Elkeles, CEO and cofounder of Israeli femtech hub Eve.
